AndreaJBullockMD

Oncology • Boston, MA

Gastrointestinal Cancer

Hematology/Oncology

Join to view full profile

Dr. Bullock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bullock's full profile

Already have an account?

Office
330 Brookline Ave
# Shapiro
Boston, MA 02215
Phone+1 617-667-7000

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
Washington University in St. Louis School of MedicineClass of 2004

Certifications & Licensure

MA State Medical License 2006 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors Start of enrollment: 2012 Oct 01
Completed
Phase 1
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Completed
Phase 2
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer Start of enrollment: 2020 May 18
Active, not recruiting
Phase 2
Niraparib + Dostarlimab + RT in Pancreatic Cancer Start of enrollment: 2020 Jul 23
Completed
Phase 2
Nivolumab+Ipilimumab+RT in MSS mCRC Start of enrollment: 2020 Oct 05
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastat...
Breelyn A Wilky, Gary K Schwartz, Michael S Gordon, Anthony B El-Khoueiry, Andrea J Bullock
Journal of Clinical Oncology. 2025-01-27
Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry.
Muhammad Mohid Tahir, Aamir Ali, Imad Nasser, Diana C Dinh, Andreea M Catana
Cardiovascular and Interventional Radiology. 2025-01-14
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.
Gregory M Cote, Bose S Kochupurakkal, Khanh Do, Andrea Bullock, Michael L Cheng
Clinical Cancer Research. 2025-01-06

Journal Articles

Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer
Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature

Lectures

Real-world assessment of healthcare costs for patients with metastatic pancreatic cancer following first-line chemotherapy initiation.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Researchers Discuss Future of Cancer Therapies at 15th Annual Cancer SymposiumNovember 11th, 2022
Researchers Discuss the Future of Cancer Therapies at 15th Annual Cancer SymposiumNovember 10th, 2022
Folfox+Irinotecan+Chemort in Esophageal CancerDecember 7th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member